摘要:
Games related to the provision of information are described. Games may be formulated to exploit biases such as long shot bias and favorite bias. Games related to the provision of information are described. Games may be formulated to exploit biases relating to the Monty Hall paradox. Games related to the provision of information are described. Games may include wagering on hands of cards, e.g., poker wagering games.
摘要:
Processes for enhancing blown film processability and the blown films formed thereby are described herein. One embodiment of the processes generally includes providing a first propylene based heterophasic copolymer having a first melt flow rate, modifying the first propylene based heterophasic copolymer to form a second heterophasic polymer having a second melt flow rate, wherein the second melt flow rate is greater than the first melt flow rate, contacting the first heterophasic polymer, the second heterophasic copolymer or a combination thereof with a plurality of additives, wherein the plurality of additives include a nucleator, polyethylene and mineral oil to form a modified heterophasic copolymer and blowing the modified heterophasic polymer into a film.
摘要:
An electronic trading marketplace (ETM) communicates with interfacing modules interfacing directly with order management systems (OMS's) at trading institutions. The interfacing modules automatically transmit orders from the OMS databases to the ETM and update the OMS databases in response to orders executed at the ETM. Traders can communicate with the ETM to anonymously negotiate trades of securities.
摘要:
The present invention relates to modulators of cystic fibrosis Transmembrane Conductance Regulator (“CFTR”), compositions thereof, and methods therewith. The present invention also relates to methods of treating CFTR mediated diseases using such modulators.
摘要:
A runtime activation system uses a set of policies designed to provide a balance between backwards compatibility and ease of migrating existing (non side-by-side aware) applications to new runtime versions. The system chooses the runtime version to activate when an application runs or when a runtime application programming interface is invoked based on the set of policies. The system implements these policies by consulting compatibility data associated with the application indicating the intent of the author and level of side-by-side support provided by the application and/or global configuration data. Based on the compatibility data, the system chooses policies that are right in the most common cases, and easy to modify in less common cases. Thus, the runtime activation system allows applications to be flexibly configured to handle new runtime versions in a manner determined by the application author, a system administrator, or others.
摘要:
A communication system transmitting signals over a network using a transmission waveform in which a plurality of data packets are transmitted in a payload field of a transmission frame, the system includes a transmitter, which has a transmitting portion that sends information including user data in the data packets and a user data rate portion that dynamically changes the data rate of the user data to the highest rate possible for current link conditions by changing the waveform. The communication system also includes a receiver, which has a receiving portion that receives the information data packets and a reconfiguration portion that reconfigures the receiving portion based on the waveform parameters.
摘要:
Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.
摘要:
Compounds of the present invention, and pharmaceutically acceptable compositions thereof, are useful as modulators of ATP-Binding Cassette (“ABC”) transporters or fragments thereof, including Cystic Fibrosis Transmembrane Conductance Regulator (“CFTR”). The present invention also relates to methods of treating ABC transporter mediated diseases using compounds of the present invention.